Global Breast Imaging Technologies Market Size Study, by Type (Mammography, Breast Ultrasound, Breast MRI, Image-Guided Breast Biopsy, Other Imaging Techniques) and Regional Forecasts 2022-2032

Global Breast Imaging Technologies Market is valued at approximately USD 5.46 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.51% over the forecast period 2024-2032. Breast Imaging Technologies encompass a range of medical techniques, including mammograms, ultrasounds, and MRI scans, that are pivotal in examining breast tissue for abnormalities. These technologies are indispensable for early detection, diagnosis, and monitoring of breast conditions, particularly breast cancer. Several key factors are fueling the growth of this market. Primarily, there is a heightened focus on early diagnosis and preventive medicine, which is driving the demand for advanced screening technologies and diagnostic tools. Additionally, the rising prevalence of breast cancer cases necessitates effective diagnostic and treatment solutions, further propelling market expansion. Moreover, the increasing number of mergers and acquisitions in the healthcare sector enhances companies' capabilities and reach, leading to more integrated and comprehensive healthcare offerings.

The market is crucial for detecting and diagnosing breast-related disorders. Advanced methods like radiological imaging, breast ultrasonography, MRI, and nuclear imaging are extensively employed in hospitals and diagnostic imaging centers. These diagnostic radiology tools are vital in identifying breast lesions and diagnosing invasive breast cancer cases. Technologies such as CT scans, PET scans, and X-rays are essential in detecting cancer-related deaths among women. The market is driven by the demand for breast imaging equipment, automation, and AI, providing state-of-the-art equipment for both small-scale users and diagnostic centers. Increasing investment in diagnostic imaging devices by breast care centers underscores the commitment to enhancing breast health diagnostics.

The increasing global prevalence of breast cancer and other breast-related disorders drives the demand for advanced breast imaging technologies. According to the World Health Organization (WHO), breast cancer is the most common cancer among women worldwide, significantly contributing to cancer mortality rates. This prevalence underscores the critical need for early detection and effective diagnostic tools, which are pivotal in improving patient outcomes. However, lack of knowledge and low adoption of ABUS and high costs associated with advanced imaging technologies are the key factors that are substantially halting the growth of the market globally. Furthermore, the rising technological advancements in breast imaging, including the integration of artificial intelligence (AI) and machine learning, are revolutionizing the field. AI-enhanced imaging systems can assist radiologists in detecting subtle abnormalities and provide more accurate interpretations of breast images. Additionally, innovations such as 3D mammography (tomosynthesis) and automated breast ultrasound (ABUS) offer improved imaging capabilities, particularly for women with dense breast tissue, thereby driving market growth.

The key regions considered for the global Breast Imaging Technologies Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Breast Imaging Technologies Market in terms of revenue. The market growth in the region is being attributed to factors including advancements in healthcare infrastructure, increased awareness, and augmented healthcare finances. The U.S. sees significant demand for automated pill dispensers from the home healthcare segment, driven by a growing aging population. In March 2024, Roche received U.S. FDA approval for its cobas Malaria test for use on the cobas 6800/8800 Systems, aimed at reducing the potential risk of malarial infection from transfused blood products. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by rising prevalence of breast cancer, increasing healthcare expenditure, growing awareness about early detection, rapid urbanization, and expanding healthcare infrastructure. These factors are driving demand for advanced imaging technologies to improve diagnosis and treatment outcomes.

Major market players included in this report are:

• General Electric Co.
• Siemens AG
• Koninklijke Philips N.V.
• Hologic Inc.
• FUJIFILM Corp.
• Canon Inc.
• Aurora Healthcare US Corp.
• Koning Corp.
• Metaltronica Spa
• Micrima Ltd.
• Perlong Medical Equipment Co. Ltd.
• Dilon Medical Technologies Inc.
• Delphinus Medical Technologies Inc.
• SonoCine Inc.
• CMR Naviscan Corp.

The detailed segments and sub-segment of the market are explained below:

By Type:

• Mammography
• Breast Ultrasound
• Breast MRI
• Image-Guided Breast Biopsy
• Other Imaging Techniques

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.